Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Vande Woude, George F

Class:IdPerson:180250
_displayNameVande Woude, George F
_timestamp2013-12-09 21:32:33
created[InstanceEdit:180251] D'Eustachio, P, 2006-05-17 14:55:15
firstnameGeorge F
initialGF
modified[InstanceEdit:5211335] D'Eustachio, Peter, 2013-12-09
surnameVande Woude
(author)[LiteratureReference:180219] Nucleotide sequences of integrated Moloney sarcoma provirus long terminal repeats and their host and viral junctions
[LiteratureReference:5211331] Proteolytic inactivation of MAP-kinase-kinase by anthrax lethal factor
[LiteratureReference:8875787] Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis
[LiteratureReference:8931711] Met, metastasis, motility and more
[LiteratureReference:8931730] Structural basis of hepatocyte growth factor/scatter factor and MET signalling
[LiteratureReference:9734090] Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent
[Change default viewing format]
No pathways have been reviewed or authored by Vande Woude, George F (180250)